ENLIVEN Trademark

Trademark Overview

On Monday, March 23, 2015, a trademark application was filed for ENLIVEN with the United States Patent and Trademark Office. The USPTO has given the ENLIVEN trademark a serial number of 79166998. The federal status of this trademark filing is Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, September 5, 2024. This trademark is owned by DAIICHI SANKYO COMPANY, LIMITED. The ENLIVEN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

[ Conducting of clinical studies and trials for others in the field of pharmaceuticals; ] providing medical and scientific research information on clinical studies and trials of pharmaceuticals
enliven

General Information

Serial Number79166998
Word MarkENLIVEN
Filing DateMonday, March 23, 2015
Status739 - Section 71 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, September 5, 2024
Registration Number5348138
Registration DateTuesday, December 5, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 19, 2017

Trademark Statements

Goods and Services[ Conducting of clinical studies and trials for others in the field of pharmaceuticals; ] providing medical and scientific research information on clinical studies and trials of pharmaceuticals

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, June 22, 2015
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP
Party NameDAIICHI SANKYO COMPANY, LIMITED
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressTokyo 103-8426
JP

Trademark Events

Event DateEvent Description
Thursday, June 18, 2015SN ASSIGNED FOR SECT 66A APPL FROM IB
Monday, June 22, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 26, 2015APPLICATION FILING RECEIPT MAILED
Monday, June 29, 2015NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, June 24, 2015ASSIGNED TO EXAMINER
Sunday, June 28, 2015NON-FINAL ACTION WRITTEN
Monday, June 29, 2015NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 29, 2015REFUSAL PROCESSED BY MPU
Friday, December 4, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, December 4, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 4, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, December 29, 2015SUSPENSION LETTER WRITTEN
Tuesday, December 29, 2015LETTER OF SUSPENSION E-MAILED
Tuesday, December 29, 2015NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, June 29, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, November 23, 2016NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Wednesday, November 23, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Friday, December 9, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Thursday, December 29, 2016REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, July 13, 2017ASSIGNED TO LIE
Tuesday, September 19, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Saturday, July 18, 2015REFUSAL PROCESSED BY IB
Monday, July 17, 2017SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Sunday, August 13, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, August 30, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 30, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, August 30, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, September 19, 2017PUBLISHED FOR OPPOSITION
Monday, March 5, 2018FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sunday, July 3, 2022NEW REPRESENTATIVE AT IB RECEIVED
Tuesday, September 3, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, November 17, 2017NOTIFICATION PROCESSED BY IB
Tuesday, December 5, 2017REGISTERED-PRINCIPAL REGISTER
Monday, March 19, 2018FINAL DISPOSITION PROCESSED
Monday, March 19, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, May 11, 2018FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, December 5, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Tuesday, November 21, 2023TEAS SECTION 71 & 15 RECEIVED
Thursday, September 5, 2024NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Monday, May 5, 2025PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Wednesday, August 20, 2025GENERIC MADRID TRANSACTION SENT TO IB
Friday, September 19, 2025PARTIAL INVALIDATION PROCESSED BY THE IB
Wednesday, August 20, 2025GENERIC MADRID TRANSACTION CREATED
Thursday, September 5, 2024REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Thursday, April 10, 2025INTERNATIONAL REGISTRATION RENEWED

Related Keywords

enliven pharmaceuticals studies trials clinical scientific research information medical field others